Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
5.00
+0.29 (6.16%)
Nov 21, 2024, 3:54 PM EST - Market closed
Lipocine Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 27 | 15 | 35 | 88 | 89 | 14 | |
| Market Cap Growth | 51.58% | -57.88% | -59.76% | -2.05% | 547.37% | -50.55% | |
| Enterprise Value | 6 | -9 | 1 | 52 | 77 | 10 | |
| Last Close Price | 4.71 | 2.79 | 6.76 | 16.85 | 23.12 | 6.54 | |
| PS Ratio | 3.17 | -5.20 | 70.42 | 5.42 | - | 83.64 | |
| PB Ratio | 1.32 | 0.73 | 0.99 | 1.92 | 5.82 | 2.19 | |
| P/TBV Ratio | 1.26 | 0.73 | 0.99 | 1.92 | 5.82 | 2.19 | |
| EV/Sales Ratio | 0.70 | - | 2.19 | 3.23 | - | 62.59 | |
| EV/EBITDA Ratio | - | - | - | 16.57 | - | - | |
| EV/EBIT Ratio | - | - | - | 16.57 | - | - | |
| Debt / Equity Ratio | 0.01 | 0.02 | - | 0.05 | 0.36 | 1.14 | |
| Debt / EBITDA Ratio | - | - | - | 0.73 | - | - | |
| Asset Turnover | 0.35 | - | 0.01 | 0.41 | - | 0.01 | |
| Quick Ratio | 12.59 | 8.39 | 19.78 | 7.99 | 2.99 | 2.84 | |
| Current Ratio | 12.97 | 8.69 | 20.34 | 8.26 | 3.85 | 3.95 | |
| Return on Equity (ROE) | -19.50% | -58.40% | -26.50% | -2.08% | -193.85% | -165.47% | |
| Return on Assets (ROA) | -14.56% | -37.02% | -16.83% | 5.05% | -49.98% | -39.81% | |
| Return on Capital (ROIC) | -15.79% | -39.72% | -18.14% | 5.71% | -65.45% | -48.67% | |
| Earnings Yield | -16.11% | -110.25% | -30.56% | -0.72% | -23.47% | -94.26% | |
| FCF Yield | -19.99% | -80.10% | -34.37% | -5.05% | -17.13% | -84.54% | |
| Buyback Yield / Dilution | -1.56% | -0.26% | -1.98% | -57.35% | -115.16% | -21.22% | |
| Total Shareholder Return | -1.56% | -0.26% | -1.98% | -57.35% | -115.16% | -21.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.